COVID-19 in People with Arthritis COVID-19 in People with Arthritis

Dr Fotini Soliotis, consultant rheumatologist at Poole Hospital in Dorset, talks us through how COVID-19 affects arthritis patients and their treatments.Medscape
Source: Medscape Today Headlines - Category: Consumer Health News Tags: None ReCAP Guidance Source Type: news

Related Links:

(Natural News) If you only listened to the mainstream media, you might think hydroxychloroquine is a risky medication that does nothing to help COVID-19 patients, but the truth is that it’s a drug that has been used for 65 years to prevent and treat illnesses like lupus, malaria and rheumatoid arthritis and has been officially...
Source: NaturalNews.com - Category: Consumer Health News Source Type: news
(Florida Atlantic University) Researchers urge a moratorium on prescribing chloroquine or hydroxychloroquine, with or without azithromycin, to treat or prevent COVID-19, and caution that the reassuring safety profile of hydroxychloroquine may be more apparent than real. Safety data derive from decades of prescriptions by clinicians, primarily for their patients with lupus and rheumatoid arthritis, both of which are of greater prevalence in younger and middle age women, who are at very low risk of fatal heart outcomes due to hydroxychloroquine.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
(Uppsala University) Researchers at Uppsala University and Uppsala University Hospital have developed a new method to measure levels of the medication hydroxychloroquine in patients with the rheumatic disease systemic lupus erythematosus (SLE). The analysis method may also be useful in other areas, such as in the treatment of COVID-19. The study is being published in Arthritis Research and Therapy.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
Conditions:   Juvenile Idiopathic Arthritis;   COVID 19;   Treatment Intervention:   Sponsor:   University Hospital, Brest Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COVID-19;   Rheumatoid Arthritis Intervention:   Other: Serological analyses to be lead on a pre-existing biobank Sponsor:   University Hospital, Montpellier Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Juvenile Idiopathic Arthritis;   COVID 19;   Treatment Intervention:   Sponsor:   University Hospital, Brest Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COVID-19;   Rheumatoid Arthritis Intervention:   Other: Serological analyses to be lead on a pre-existing biobank Sponsor:   University Hospital, Montpellier Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Juvenile Idiopathic Arthritis;   COVID 19;   Treatment Intervention:   Sponsor:   University Hospital, Brest Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COVID-19;   Rheumatoid Arthritis Intervention:   Other: Serological analyses to be lead on a pre-existing biobank Sponsor:   University Hospital, Montpellier Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Juvenile Idiopathic Arthritis;   COVID 19;   Treatment Intervention:   Sponsor:   University Hospital, Brest Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arthritis | COVID-19 | Health | Hospitals | Rheumatology